Kura Oncology Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Kura Oncology Inc.
Former names: Zeta Acquisition Corp III
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: SAN Diego
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: KURA
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001422143
EIN: 61-1547851

Board of directors

Follow this board

Carol Schafer · Director
Since 2023
Diane L. Parks · Director
Since 2023
Faheem Hasnain · Director
Since 2023
Helen Louise Collins · Director
Since 2023
Mary T. Szela · Director
Since 2023
Michael Vasconcelles · Director
Since 2024
Thomas Malley · Director
Since 2023
Troy Edward Wilson · Director · President and CEO
Since 2023

Chief executives

Troy Edward Wilson · President and CEO

Dates unknown

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 15 other boards. 14 are in the same sector.

Shared director Other board Same sector

Absci Corporation Same sector
via Mary T. Szela
Aspen Neuroscience Inc. Same sector
via Faheem Hasnain
Atrium Therapeutics Inc. Same sector
via Troy Edward Wilson
Averin Capital Acquisition Corp.
via Mary T. Szela
BeOne Medicines Ltd. Same sector
via Thomas Malley
Celularity Inc. Same sector
via Diane L. Parks
Enliven Therapeutics Inc. Same sector
via Helen Louise Collins
Gossamer Bio Inc. Same sector
via Faheem Hasnain
Immunome Inc. Same sector
via Carol Schafer
Insmed Incorporated Same sector
via Carol Schafer
Kiniksa Pharmaceuticals International plc Same sector
via Thomas Malley
MacroGenics Inc. Same sector
via Michael Vasconcelles
Puma Biotechnology Inc Same sector
via Troy Edward Wilson
Soligenix Inc. Same sector
via Diane L. Parks
TriSalus Life Sciences Inc. Same sector
via Mary T. Szela

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $2,351,000; 2 purchases by 1 insider
Sold, last 12 months: $3,842,725; 40 sales by 7 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 29, 2026	FORD KATHLEEN Officer (Chief Operating Officer)	Open-market sale	−3,668	$10.75	$39,431
Sep 29, 2026	Leoni Mollie Officer (Chief Medical Officer)	Open-market sale	−28,802	$10.75	$309,622
Sep 29, 2026	Powl Brian T. Officer (Chief Commercial Officer)	Open-market sale	−15,430	$10.75	$165,873
Sep 28, 2026	Bair Teresa Brophy Officer (Chief Legal Officer)	Open-market sale	−8,442	$10.50	$88,641
Sep 28, 2026	DOYLE THOMAS JAMES Officer (SVP, Finance & Accounting)	Open-market sale	−4,607	$10.50	$48,374
Sep 28, 2026	FORD KATHLEEN Officer (Chief Operating Officer)	Open-market sale	−6,906	$10.50	$72,513
Sep 28, 2026	Powl Brian T. Officer (Chief Commercial Officer)	Open-market sale	−9,020	$10.50	$94,710
Sep 28, 2026	Leoni Mollie Officer (Chief Medical Officer)	Open-market sale	−12,448	$10.50	$130,704
Sep 28, 2026	Powl Brian T. Officer (Chief Commercial Officer)	Open-market sale	−8,000	$10.56	$84,480
Sep 24, 2026	Burrows Francis Officer (Chief Scientific Officer)	Option exercise	+30,000	$6.15	$184,500
Sep 24, 2026	Burrows Francis Officer (Chief Scientific Officer)	Open-market sale	−20,726	$10.83	$224,463
Aug 24, 2026	Troy Edward Wilson Director, Officer (President and CEO)	Open-market purchase	+100,000	$12.39	$1,239,000
Aug 21, 2026	Powl Brian T. Officer (Chief Commercial Officer)	Open-market sale	−4,345	$11.89	$51,662
Aug 19, 2026	Bair Teresa Brophy Officer (Chief Legal Officer)	Open-market sale	−31,487	$12.63	$397,681
Aug 17, 2026	Troy Edward Wilson Director, Officer (President and CEO)	Open-market purchase	+100,000	$11.12	$1,112,000

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Kura Oncology Inc.

Who is the CEO of Kura Oncology Inc.?

Troy Edward Wilson is Kura Oncology Inc.'s President and CEO.

How many directors are on Kura Oncology Inc.'s board?

Kura Oncology Inc.'s board has 8 directors: Carol Schafer, Diane L. Parks, Faheem Hasnain, Helen Louise Collins, Mary T. Szela, Michael Vasconcelles, Thomas Malley and Troy Edward Wilson.

Are Kura Oncology Inc. insiders buying or selling shares?

Over the last 12 months, Kura Oncology Inc. insiders bought $2.4 million of shares in 2 purchases and sold $3.8 million of shares in 40 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Kura Oncology Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="kura-oncology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.